However, our results did support those found by Neth et al. [23], which suggested that donors’ MBL2 genotype did not influence infection rates, and the results of Rocha et al. [21], who examined 107 HLA identical sibling Allo-HSCT recipients with myeloablative conditioning and found no association between MBL2 gene polymorphisms and the development of bacterial, viral or fungal infections during the first 180 days after transplant. This evidence concerns the gene MBL2 and fungal infectious disease.